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Supplemental Figure 1. Timed induction of AG activity. 
Inflorescences of ag-1 35S:AG-GR were untreated (A) or treated once with 1 μM DEX (B), once 
(C), twice (D), three times (E) and four times (F) with 10 μM DEX at 12-hour intervals. Photos 
were taken 12 days after the initial treatments. 
Supplemental Data. Ito et al. (2007). The homeotic protein AGAMOUS controls late stamen
development by regulating a jasmonate biosynthetic gene in Arabidopsis.
Supplemental Figure 2. Effects of 4 DEX treatments to floral buds at earlier stages than stage 3. 
Inflorescences of ag-1 35S:AG-GR were treated four times with 10 μM DEX at 12 hour intervals. 
Photos were taken after 13 days (A) or 14 days (B) from the initial treatments. 
Supplemental Figure 3. ChIP assay using ag-1 35S:AG-GR inflorescences in day 3 after DEX treatments.
Nuclear extract of ag-1 35S:AG-GR inflorescences in day 3 after DEX treatments was immunopurified by 
AG-specific antibody (shown as black bars) or IgG control (gray bars). Primers used for analysis were 
shown in A and supplemental Table 1. Y-axis shows enrichment rates compared with an unrelated control 
gene. In day 3, no significant enrichment of DAD1 promoter regions were observed. 
Supplemental Figure 4. ChIP assay of AG binding to DAD1 promoter in ap1 cal 35:AP1-GR. 
The inflorescences were treated once with 1 μM DEX and harvested 2 days or 6 days after 
treatment. The floral buds reached stage 3 and stage 8-9 in 2 days and 6 days after the treatment, 
respectively {Wellmer, 2006 #117}. The experiment was performed in the same way as that 
shown in figure 7I. In day 2 samples, no enrichment was observed, but in day 6 samples, weak 
but distinct enrichment was detected. Bars show standard errors. 
Supplemental Table 1. Primer sequences used in this study. 
 All are shown in 5’-3’ direction. 
 
RT-PCR primers. 
DAD1-F, TTACGGCGACGAGCCGTTAAGTGTAA 
DAD1-R, TGGAGAACTCTCCGAGCTGTTTCTCT 
COI1-F, CCAATACTATTTCCATTCGCGGCCC 
COI1-R, CACGTTTGGACTGTACTGTCCGATGT 
OPR3-F, CCCACATGTGCCTGGAATCTATTCAG 
OPR3-R, AGCCCGAGTGATAGTGGGTCAGAAT 
 
Real-time PCR primers (two sets of DAD1 primers were tested showing similar results).  
DAD1R-1F, ACGATAACCGGTCACAGCCTCG 
DAD1R-1R, TGTTTCCGACACGTGGACCTCC  
DAD1R-2F, TCGGTAAGGAGCTTCGGCTGAG  
DAD1R-2R, CTGAATGGACACGTGGAGCTCAC  
COI1R-F, GTGAGCGAGCAATCGCTGCAGC  
COL1R-R, CAGCTCGATGTTCCAGTACGGTC  
OPR3R-F, GGACGCAACTGATTCTGACCCAC  
OPR3R-R, CGTAGGCGTGGTAGCGAGGTTG 
 
Cloning of DAD1 promoter.
DAD1-5A2, CACCTTGCATGTAAACTTAATGTCACTATTCCCTA 
DAD1-5B, ATCTCCGGCCAAGCTTAACCGGGA 
 
Mutagenesis of CArG box. 
DAD1-5'MA2 
GTGTAGTAGTACCTTCACTAGGAAAACACCACGTCGTTTCTTATATAAGTG 
DAD1-5'MB2 
CACTTATATAAGAAACGACGTGGTGTTTTCCTAGTGAAGGTACTACTACAC  
 
ChIP primers. 
DAD1C-1F, ACGTAGAATCCATTCATGATCCCAAATAT 
DAD1C-1R, GTGGTACACATAAGCTATGTTTGCTC  
DAD1C-2F, AACACACACACACTTTCTCAACAAT  
DAD1C-2R, CATTGACGATTCGACGTCGTACCAC 
DAD1C-3F, AGATGACAGCGTCGATAATGCC  
DAD1C-3R, TACCGATTTCAGCGTAAACCC 
Mu-likeF, GATTTACAAGGAATCTGTTGGTGGT 
Mu-likeR, CATAACATAGGTTTAGAGCATCTGC 
PFK-1F, TGGCATCACAATTAGATTTGATCGG  
PFK-1R, TACAGAAGTCACACGGCTATTCGTC 
 
Sequencing primers for DAD1 promoter constructs. 
DAD1-7A, CCTTTGTGTTGAGTAATTTCGTTGTATAGGC 
DAD1-7B, CCGTTAAACCATCAGAAGCCAGCTAACA 
DAD1-8A, GTGGTGTGTAGTATTGTGTCCACAAATATATG 
DAD1-8B, GGAGTGATAGCCATGACATCAACT 
DAD1-90B, GATAACCATCGTGATTTCTGAAAGACTG 
DAD1-9A, GCATTCAAACGATGTGATAATGTGAAATGC 
DAD1-9B, GCATTTCACATTATCACATCGTTTGAATGC 
DAD1-10A, GCACAAGACTAATATATAAAGAGCTACGAC 
DAD1-10B, GTTGGAGTGATGTGTTGTTCGGGC 
DAD1-11A, CGACGGTCAGATATTTATTTCGATACACAC 
DAD1-11B, AAGGATTTAACCGAATTGGTGACCA 
DAD1-120B, GTGATTGAAGGAAAGAGGAAATGGG 
DAD1-12A, CAACAATCTCTTTAACTCCACTATAGATCCC 
DAD1-13A, GGAACCGCCACGTGTCTCGA 
DAD1-13B, GAACTTTGGTGATGACGTCGTCGG 
DAD1-14A, GCGTCGATAATGCCGAGCTGGA 
DAD1-15A, GGCGGCGAATGGCTAAAGCC 
DAD1-15B, GGGACTGGACACGTGGGAGT 
DAD1-16A, CCCAGCTATTGTTAGCTTTCTAATTTGG 
DAD1-16B, GGACTCGACTCTGAAAATTGTGGACAG 
DAD1- 40B, CCACGCCCTTCTAGGCTTCTAG 
 
